We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+27.94%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
AUM
$556M
AUM Growth
+$97.3M
Cap. Flow
-$17.8M
Cap. Flow %
-3.2%
Top 10 Hldgs %
43.97%
Holding
352
New
25
Increased
29
Reduced
61
Closed
17

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$2.79M
2
RTX icon
RTX Corp
RTX
+$1.69M
3
FIVN icon
FIVE9
FIVN
+$1.44M
4
LVS icon
Las Vegas Sands
LVS
+$1.44M
5
QSR icon
Restaurant Brands International
QSR
+$1.42M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.02M
2
AMZN icon
Amazon
AMZN
+$2.94M
3
XYL icon
Xylem
XYL
+$2.82M
4
V icon
Visa
V
+$2.28M
5
HON icon
Honeywell
HON
+$1.98M

Sector Composition

Rank Sector Weight
1 Technology 31.82%
2 Healthcare 14.48%
3 Consumer Discretionary 14.42%
4 Communication Services 12.19%
5 Financials 12.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCSA icon
26
Comcast
CMCSA
$87.3B
$4.44M 0.8%
113,227
-8,410
-7% -$320K
EL icon
27
Estee Lauder
EL
$30.4B
$4.38M 0.79%
23,219
-1,488
-6% -$266K
HON icon
28
Honeywell
HON
$76.4B
$4.19M 0.75%
30,724
-14,985
-33% -$1.98M
WDAY icon
29
Workday
WDAY
$41.5B
$4.17M 0.75%
22,250
-1,442
-6% -$233K
VRTX icon
30
Vertex Pharmaceuticals
VRTX
$123B
$4.11M 0.74%
14,161
-949
-6% -$257K
AMAT icon
31
Applied Materials
AMAT
$347B
$4.07M 0.73%
67,346
-3,653
-5% -$197K
EQIX icon
32
Equinix
EQIX
$99.4B
$3.77M 0.68%
5,375
-345
-6% -$233K
QCOM icon
33
Qualcomm
QCOM
$164B
$3.74M 0.67%
41,035
-2,189
-5% -$176K
JPM icon
34
JPMorgan Chase
JPM
$916B
$3.67M 0.66%
39,052
KNX icon
35
Knight Transportation
KNX
$11.5B
$3.62M 0.65%
86,728
-5,610
-6% -$214K
MCD icon
36
McDonald's
MCD
$193B
$3.58M 0.64%
19,394
BMY icon
37
Bristol-Myers Squibb
BMY
$129B
$3.57M 0.64%
60,713
-3,681
-6% -$220K
BAC icon
38
Bank of America
BAC
$429B
$3.44M 0.62%
144,678
RSG icon
39
Republic Services
RSG
$67.4B
$3.29M 0.59%
39,906
MDT icon
40
Medtronic
MDT
$112B
$3.21M 0.58%
34,788
MTD icon
41
Mettler-Toledo International
MTD
$28.1B
$3.08M 0.55%
3,829
-248
-6% -$184K
ISRG icon
42
Intuitive Surgical
ISRG
$127B
$3.04M 0.55%
16,002
-1,026
-6% -$184K
PFE icon
43
Pfizer
PFE
$143B
$2.97M 0.53%
95,696
SPLK
44
DELISTED
Splunk Inc
SPLK
$2.9M 0.52%
14,575
-929
-6% -$147K
CME icon
45
CME Group
CME
$95.4B
$2.85M 0.51%
17,539
TXN icon
46
Texas Instruments
TXN
$248B
$2.82M 0.51%
22,202
MRK icon
47
Merck
MRK
$322B
$2.81M 0.51%
37,768
FIS icon
48
Fidelity National Information Services
FIS
$24.2B
$2.79M 0.5%
20,795
DPZ icon
49
Domino's
DPZ
$11.9B
$2.72M 0.49%
7,369
CVS icon
50
CVS Health
CVS
$135B
$2.69M 0.48%
41,440
+598
+1% +$37.7K

Similar funds

Silvant Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Silvant Capital Management held 352 positions worth $556M, up 21% from $459M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Silvant Capital Management withdrew a net $17.8M in Q2 2020, closing 17 positions and reducing 61 holdings. Its most notable exit was Xylem, an estimated $2.82M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Silvant Capital Management opened a new position in Las Vegas Sands worth $1.4M.

  • Silvant Capital Management's largest Q2 2020 buy was Las Vegas Sands: 30,631 shares worth $1.4M.
  • Silvant Capital Management added most to Boeing in Q2 2020, an estimated $2.79M increase.
  • Silvant Capital Management's biggest Q2 2020 reduction was Microsoft, cutting an estimated $3.02M.
  • Silvant Capital Management fully exited Xylem in Q2 2020, selling an estimated $2.82M.
  • Silvant Capital Management's ten largest holdings make up 44% of its $556M portfolio in Q2 2020.
  • Silvant Capital Management opened 25 new positions and closed 17 in Q2 2020.
  • Silvant Capital Management's portfolio value rose 21% quarter-over-quarter to $556M.

Based on Silvant Capital Management's 13F filing for Q2 2020, filed 11 Aug 2020.